Pharming Group Balance Sheet Health
Financial Health criteria checks 6/6
Pharming Group has a total shareholder equity of $218.8M and total debt of $138.4M, which brings its debt-to-equity ratio to 63.3%. Its total assets and total liabilities are $462.9M and $244.1M respectively.
Key information
63.3%
Debt to equity ratio
US$138.42m
Debt
Interest coverage ratio | n/a |
Cash | US$213.42m |
Equity | US$218.78m |
Total liabilities | US$244.07m |
Total assets | US$462.85m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHGU.F's short term assets ($316.3M) exceed its short term liabilities ($78.0M).
Long Term Liabilities: PHGU.F's short term assets ($316.3M) exceed its long term liabilities ($166.1M).
Debt to Equity History and Analysis
Debt Level: PHGU.F has more cash than its total debt.
Reducing Debt: PHGU.F's debt to equity ratio has reduced from 117.4% to 63.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable PHGU.F has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: PHGU.F is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 24.7% per year.